Southern Research Institute
UEI CDZJAJJHJMH5 · AL · SAM.gov record ↗
$-3.2M
FY2025 obligations
23
Contract awards
Jul 13, 2008
First action
Mar 26, 2026
Latest action
Obligations by agency
- Department Of Defense$0
- National Aeronautics And Space Administration$-703
- Department Of Health And Human Services$-3.2M
Obligations by NAICS
Monthly obligations
Oct 24
Nov 24
Dec 24
Jan 25
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Nov 25
Jan 26
Mar 26
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50123F61001 ↗ | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | Office Of Assistant Secretary For Preparedness And Response | 541714 | $5K | Jul 19, 2023 | Jul 18, 2026 |
| 75N93023F00001 ↗ | CONDUCT HIT-TO-LEAD PROGRESSION STUDIES ON INTERVENTIONAL AGENTS: IDENTIFICATION OF ANTI-HIV LEAD COMPOUNDS | National Institutes Of Health | 541715 | $0 | Aug 31, 2023 | Aug 30, 2026 |
| 75N93021F00003 ↗ | CONDUCT CONFIRMATORY AND SPECIALIZED IN VITRO TESTING AND SCREENING OF INTERVENTIONAL AGENTS IN STANDARD FORMATS (TASK AREA A). | National Institutes Of Health | 541715 | $0 | Aug 31, 2021 | Aug 30, 2026 |
| 75N93022F00001 ↗ | NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES | National Institutes Of Health | 541714 | $0 | May 18, 2022 | Apr 29, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93021F00001 ↗ | NON-CLINICAL SERVICES FOR DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES | National Institutes Of Health | 541714 | $346K | Sep 26, 2021 | Jan 30, 2026 |
| 75N93024F00001 ↗ | PHARMACOKINETICS OF LONG-ACTING PREPARATIONS OF TELACEBEC (Q203) IN SPRAGUE DAWLEY RATS | National Institutes Of Health | 541715 | $15K | Jun 30, 2024 | Jun 29, 2025 |
| 75N93025D00024 ↗ | "EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES." | National Institutes Of Health | 541715 | $10K | Sep 29, 2025 | — |
| 75A50123F61001 ↗ | BIO-AMT-2301: IDIQ CONTRACT MANAGEMENT SUPPORT ACTIVITIES | Office Of Assistant Secretary For Preparedness And Response | 541714 | $5K | Jul 19, 2023 | Jul 18, 2026 |
| 75N93019D00014 ↗ | IN VITRO ASSESSMENTS OF ANTIMICROBIAL ACTIVITY - TASK AREA A | National Institutes Of Health | 541714 | $0 | Jan 10, 2019 | — |
| FA865019C5210 ↗ | NONDESTRUCTIVE EVALUATION OF POLYMER MATRIX COMPOSITES THROUGH COATINGS | Department Of The Air Force | 541715 | $0 | Jan 28, 2019 | Feb 27, 2026 |
| 75N93021F00003 ↗ | CONDUCT CONFIRMATORY AND SPECIALIZED IN VITRO TESTING AND SCREENING OF INTERVENTIONAL AGENTS IN STANDARD FORMATS (TASK AREA A). | National Institutes Of Health | 541715 | $0 | Aug 31, 2021 | Aug 30, 2026 |
| 75N93023F00001 ↗ | CONDUCT HIT-TO-LEAD PROGRESSION STUDIES ON INTERVENTIONAL AGENTS: IDENTIFICATION OF ANTI-HIV LEAD COMPOUNDS | National Institutes Of Health | 541715 | $0 | Aug 31, 2023 | Aug 30, 2026 |
| 75N93022F00001 ↗ | NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES | National Institutes Of Health | 541714 | $0 | May 18, 2022 | Apr 29, 2027 |
| 75N95019D00034 ↗ | EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE. CRO SUPPORT FOR NCATS MEDICINAL CHEMISTRY FOR LEAD OPTIMIZATION. | National Institutes Of Health | 541715 | $0 | Sep 25, 2019 | — |
| 75N93025D00013 ↗ | INTERVENTIONAL AGENTS SAFETY AND PHARMACOKINETIC SERVICES | National Institutes Of Health | 541714 | $0 | Sep 14, 2025 | — |
| 75N93021D00010 ↗ | THE CONTRACTOR SHALL PROVIDE PRECLINICAL DEVELOPMENT SUPPORT FOR CANDIDATE PRODUCTS AND DRUG DEVELOPMENT ACTIVITIES. THE SCOPE OF WORK ENCOMPASSES ACTIVITIES THAT RANGE FROM INITIAL PRODUCT DISCOVERY TO THOSE REQUIRED TO SUPPORT CLINICAL TRIALS AND/O | National Institutes Of Health | 541715 | $0 | Oct 14, 2020 | — |
| 80MSFC19F0135 ↗ | MATERIAL CHARACTERIZATION FOR THE FABLAB PHASE A EFFORT FROM TECHSHOT AND INTERLOG | National Aeronautics And Space Administration | 541380 | $-703 | Jul 24, 2019 | Feb 27, 2020 |
| HHSO100200800046I ↗ | DEOBLIGATION OF EXCESS FUNDS | Office Of Assistant Secretary For Preparedness And Response | 325414 | $-3K | Jul 13, 2008 | — |
| 75N95018F00003 ↗ | PHARMACOKINETICS AND TOXICOLOGY DRF STUDIES - BLACKTHORNE LDT | National Institutes Of Health | 541711 | $-5K | Sep 25, 2018 | Dec 25, 2020 |
| 75N92B20P00039 ↗ | SOUTHERN RESEARCH INSTITUTE:1109391 [20-003399] | National Institutes Of Health | 541380 | $-8K | Jul 30, 2020 | Aug 30, 2022 |
| 75N93020F00001 ↗ | TO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE TASK ORDER. | National Institutes Of Health | 541711 | $-29K | Mar 26, 2020 | May 25, 2021 |
| 75N95020P00483 ↗ | DRUG DEVELOPMENT CONSULTANT SERVICES IN SUPPORT OF THE STEP UP FOR SUD PROGRAM. POP: 09/21/20-09/20/21. | National Institutes Of Health | 541690 | $-32K | Sep 20, 2020 | Sep 19, 2021 |
| HHSN27100015 ↗ | IGF OT IGF HHSN271201100005I/HHSN27100015 - IND-ENABLING STUDIES - RUC4 | National Institutes Of Health | 541711 | $-41K | Sep 16, 2015 | Nov 14, 2020 |
| 75N93020F00003 ↗ | IN VITRO TESTING RESOURCE FOR HIV THERAPEUTICS AND TOPICAL MICROBICIDES-DEOBLIGATE FUNDS FROM LINE ITEM 1 | National Institutes Of Health | 541712 | $-86K | Jul 31, 2020 | Jul 30, 2022 |
| HHSN272201500017C ↗ | QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE | National Institutes Of Health | 541711 | $-557K | Jun 24, 2015 | Sep 30, 2021 |
| HHSN273201300010C ↗ | SUPPORT OF THE RESEARCH EFFORT TO EVALUATE TOXICITY FOLLOWING EARLY LIFE EXPOSURE TO TEST ARTICLES FOR THE NTP | National Institutes Of Health | 541712 | $-1.0M | Sep 22, 2013 | Sep 21, 2023 |
| 75N93020F00002 ↗ | TO DE-OBLIGATE REMAINING FUNDS AND ADMINISTRATIVELY CLOSE THE TASK ORDER. | National Institutes Of Health | 541711 | $-1.8M | Aug 12, 2020 | Aug 30, 2022 |